Healthcare SectorGRAIL Shares Slide 20% After NHS Trial Miss Puts Galleri's FDA Path in DoubtSalvado•May 27, 2026
Biotech AcquisitionsQuest's Haystack Acquisition Faces Technology Validation Risk That Could Derail DealViaNews Editorial Team (Markets)•Feb 22, 2026
